BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 33775061)

  • 1. Hyperinsulinemia in Obesity, Inflammation, and Cancer.
    Zhang AMY; Wellberg EA; Kopp JL; Johnson JD
    Diabetes Metab J; 2021 May; 45(3):285-311. PubMed ID: 33775061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer.
    Janssen JAMJL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinemia: beneficial or harmful or both on glucose homeostasis.
    Xing J; Chen C
    Am J Physiol Endocrinol Metab; 2022 Jul; 323(1):E2-E7. PubMed ID: 35635329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin Resistance: The Increased Risk of Cancers.
    Szablewski L
    Curr Oncol; 2024 Feb; 31(2):998-1027. PubMed ID: 38392069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why does obesity increase the risk for cardiovascular disease?
    Boden G; Salehi S
    Curr Pharm Des; 2013; 19(32):5678-83. PubMed ID: 23448485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin: too much of a good thing is bad.
    Kolb H; Kempf K; Röhling M; Martin S
    BMC Med; 2020 Aug; 18(1):224. PubMed ID: 32819363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up.
    Perseghin G; Calori G; Lattuada G; Ragogna F; Dugnani E; Garancini MP; Crosignani P; Villa M; Bosi E; Ruotolo G; Piemonti L
    Acta Diabetol; 2012 Dec; 49(6):421-8. PubMed ID: 22215126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population-based observational study.
    Tsujimoto T; Kajio H; Sugiyama T
    Int J Cancer; 2017 Jul; 141(1):102-111. PubMed ID: 28390156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and cancer: a 2013 synopsis.
    Buysschaert M; Sadikot S
    Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort study.
    Fryk E; Olausson J; Mossberg K; Strindberg L; Schmelz M; Brogren H; Gan LM; Piazza S; Provenzani A; Becattini B; Lind L; Solinas G; Jansson PA
    EBioMedicine; 2021 Mar; 65():103264. PubMed ID: 33712379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of obesity in colorectal carcinogenesis].
    Hagymási K; Tulassay Z
    Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think.
    Kelly CT; Mansoor J; Dohm GL; Chapman WH; Pender JR; Pories WJ
    Surgery; 2014 Aug; 156(2):405-11. PubMed ID: 24962189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway.
    Gupta AP; Syed AA; Garg R; Goand UK; Singh P; Riyazuddin M; Valicherla GR; Husain A; Gayen JR
    Eur J Pharmacol; 2019 Dec; 864():172723. PubMed ID: 31586632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperinsulinism. Causes and mechanisms].
    Del Prato S
    Presse Med; 1992 Sep; 21(28):1312-7. PubMed ID: 1332021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperandrogenism, insulin resistance and hyperinsulinemia as cardiovascular risk factors in diabetes mellitus.
    García-Romero G; Escobar-Morreale HF
    Curr Diabetes Rev; 2006 Feb; 2(1):39-49. PubMed ID: 18220616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.
    Luchsinger JA
    Eur J Pharmacol; 2008 May; 585(1):119-29. PubMed ID: 18384771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.